Basic Information
| LncRNA/CircRNA Name | STCAT16 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | nonsteroidal anti-inflammatory drugs | |
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR |
| Sample | GC tissues, cell lines (SGC-7901,MKN-45, AGS, MGC-803, BGC-823,GES-1) |
| Expression Pattern | down-regulated |
| Function Description | Expression level of STCAT16 is downregulated in human gastric cancer.In the present study, the expression level of STCAT16 was identified to be downregulated in GC tissues and cell lines. STCAT16 downregulation was significantly associated with poor clinical features and prognosis. |
| Pubmed ID | 30957180 |
| Year | 2019 |
| Title | Long noncoding RNA STCAT16 suppresses cell growth and its expression predicts prognosis in patients with gastric cancer. |
External Links
| Links for STCAT16 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |